Literature DB >> 29291346

Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors.

Arkadi Manukyan1, Izabela Kowalczyk1, Tiffany A Melhuish1, Agata Lemiesz2, David Wotton1.   

Abstract

Myt1 and Myt1l (Myelin transcription factor 1, and Myt1-like) are members of a small family of closely related zinc finger transcription factors, characterized by two clusters of C2HC zinc fingers. Both are widely expressed during early embryogenesis, but are largely restricted to expression within the brain in the adult. Myt1l, as part of a three transcription factor mix, can reprogram fibroblasts to neurons and plays a role in maintaining neuronal identity. Previous analyses have indicated roles in both transcriptional activation and repression and suggested that Myt1 and Myt1l may have opposing functions in gene expression. We show that when targeted to DNA via multiple copies of the consensus Myt1/Myt1l binding site Myt1 represses transcription, whereas Myt1l activates. By targeting via a heterologous DNA binding domain we mapped an activation function in Myt1l to an amino-terminal region that is poorly conserved in Myt1. However, genome wide analyses of the effects of Myt1 and Myt1l expression in a glioblastoma cell line suggest that the two proteins have largely similar effects on endogenous gene expression. Transcriptional repression is likely mediated by binding to DNA via the known consensus site, whereas this site is not associated with the transcriptional start sites of genes with higher expression in the presence of Myt1 or Myt1l. This work suggests that these two proteins function similarly, despite differences observed in analyses based on synthetic reporter constructs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Myt1; Myt1l; gene expression; transcription; transcriptional repression; zinc finger

Mesh:

Substances:

Year:  2018        PMID: 29291346     DOI: 10.1002/jcb.26636

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Myt Transcription Factors Prevent Stress-Response Gene Overactivation to Enable Postnatal Pancreatic β Cell Proliferation, Function, and Survival.

Authors:  Ruiying Hu; Emily Walker; Chen Huang; Yanwen Xu; Chen Weng; Gillian E Erickson; Anastasia Coldren; Xiaodun Yang; Marcela Brissova; Irina Kaverina; Appakalai N Balamurugan; Christopher V E Wright; Yan Li; Roland Stein; Guoqiang Gu
Journal:  Dev Cell       Date:  2020-04-30       Impact factor: 12.270

2.  Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.

Authors:  Tiffany A Melhuish; Izabela Kowalczyk; Arkadi Manukyan; Ying Zhang; Anant Shah; Roger Abounader; David Wotton
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-10-10       Impact factor: 4.490

3.  MYT1 attenuates neuroblastoma cell differentiation by interacting with the LSD1/CoREST complex.

Authors:  Kai Chen; Yuanxia Cai; Cheng Cheng; Junqi Zhang; Fan Lv; Guofeng Xu; Peiwen Duan; Yeming Wu; Zhixiang Wu
Journal:  Oncogene       Date:  2020-04-06       Impact factor: 9.867

4.  MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.

Authors:  Juliette Coursimault; Anne-Marie Guerrot; Michelle M Morrow; Catherine Schramm; Francisca Millan Zamora; Anita Shanmugham; Shuxi Liu; Fanggeng Zou; Frédéric Bilan; Gwenaël Le Guyader; Ange-Line Bruel; Anne-Sophie Denommé-Pichon; Laurence Faivre; Frédéric Tran Mau-Them; Marine Tessarech; Estelle Colin; Salima El Chehadeh; Bénédicte Gérard; Elise Schaefer; Benjamin Cogne; Bertrand Isidor; Mathilde Nizon; Diane Doummar; Stéphanie Valence; Delphine Héron; Boris Keren; Cyril Mignot; Charles Coutton; Françoise Devillard; Anne-Sophie Alaix; Jeanne Amiel; Laurence Colleaux; Arnold Munnich; Karine Poirier; Marlène Rio; Sophie Rondeau; Giulia Barcia; Bert Callewaert; Annelies Dheedene; Candy Kumps; Sarah Vergult; Björn Menten; Wendy K Chung; Rebecca Hernan; Austin Larson; Kelly Nori; Sarah Stewart; James Wheless; Christina Kresge; Beth A Pletcher; Roseline Caumes; Thomas Smol; Sabine Sigaudy; Christine Coubes; Margaret Helm; Rosemarie Smith; Jennifer Morrison; Patricia G Wheeler; Amy Kritzer; Guillaume Jouret; Alexandra Afenjar; Jean-François Deleuze; Robert Olaso; Anne Boland; Christine Poitou; Thierry Frebourg; Claude Houdayer; Pascale Saugier-Veber; Gaël Nicolas; François Lecoquierre
Journal:  Hum Genet       Date:  2021-11-08       Impact factor: 4.132

5.  A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.

Authors:  Jiayang Chen; Mary E Lambo; Xia Ge; Joshua T Dearborn; Yating Liu; Katherine B McCullough; Raylynn G Swift; Dora R Tabachnick; Lucy Tian; Kevin Noguchi; Joel R Garbow; John N Constantino; Harrison W Gabel; Keith B Hengen; Susan E Maloney; Joseph D Dougherty
Journal:  Neuron       Date:  2021-10-05       Impact factor: 17.173

6.  PSI-Sigma: a comprehensive splicing-detection method for short-read and long-read RNA-seq analysis.

Authors:  Kuan-Ting Lin; Adrian R Krainer
Journal:  Bioinformatics       Date:  2019-12-01       Impact factor: 6.931

7.  Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.

Authors:  Aleksandra Gruca; Joanna Ziemska-Legiecka; Patryk Jarnot; Elzbieta Sarnowska; Tomasz J Sarnowski; Marcin Grynberg
Journal:  BMC Bioinformatics       Date:  2021-04-08       Impact factor: 3.169

Review 8.  Transcription Factors with Targeting Potential in Gliomas.

Authors:  Angeliki-Ioanna Giannopoulou; Dimitrios S Kanakoglou; Christina Piperi
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 9.  MYT1L in the making: emerging insights on functions of a neurodevelopmental disorder gene.

Authors:  Jiayang Chen; Allen Yen; Colin P Florian; Joseph D Dougherty
Journal:  Transl Psychiatry       Date:  2022-07-22       Impact factor: 7.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.